Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables (2020 - 2024)

Historic Receivables for Cellebrite DI (CLBT) over the last 5 years, with Q4 2024 value amounting to $163.7 million.

  • Cellebrite DI's Receivables fell 164.86% to $163.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $163.7 million, marking a year-over-year decrease of 164.86%. This contributed to the annual value of $163.7 million for FY2024, which is 164.86% down from last year.
  • Latest data reveals that Cellebrite DI reported Receivables of $163.7 million as of Q4 2024, which was down 164.86% from $166.4 million recorded in Q4 2023.
  • In the past 5 years, Cellebrite DI's Receivables ranged from a high of $166.4 million in Q4 2023 and a low of $100.2 million during Q4 2020
  • In the last 5 years, Cellebrite DI's Receivables had a median value of $160.3 million in 2022 and averaged $146.1 million.
  • Per our database at Business Quant, Cellebrite DI's Receivables soared by 3944.55% in 2021 and then plummeted by 164.86% in 2024.
  • Cellebrite DI's Receivables (Quarter) stood at $100.2 million in 2020, then soared by 39.45% to $139.8 million in 2021, then grew by 14.69% to $160.3 million in 2022, then grew by 3.84% to $166.4 million in 2023, then decreased by 1.65% to $163.7 million in 2024.
  • Its Receivables stands at $163.7 million for Q4 2024, versus $166.4 million for Q4 2023 and $160.3 million for Q4 2022.